This startup develops a wearable capnograph that measures carbon dioxide (CO2) in a patient's exhaled breath. The device integrates with oxygen therapy and provides continuous respiratory monitoring, enabling clinicians to track patient ventilation and improve care.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for monitoring a patient's exhaled carbon dioxide (CO2) levels often require cumbersome equipment and are not easily integrated into various care settings. This can limit the ability to continuously track patient ventilation, especially in home care, emergency care, and procedural sedation scenarios. The lack of convenient and reliable CO2 monitoring can hinder timely intervention and optimization of respiratory support.
Solution
Oxlantic Medical has developed a wearable capnograph that provides continuous, real-time monitoring of exhaled CO2. The device features a lightweight (1.5g) sensor that seamlessly integrates with oxygen therapy delivery systems. This allows clinicians to track patient ventilation in a variety of settings, including home care, emergency care, and during procedural sedation. By providing continuous respiratory monitoring, the device enables timely detection of changes in a patient's respiratory status, facilitating proactive adjustments to their care plan and potentially improving patient outcomes.
Target Audience
The primary target audience includes healthcare providers in home care, emergency medicine, and procedural sedation, as well as hospitals and clinics seeking to improve respiratory monitoring capabilities.
Features
- Lightweight (1.5g) CO2 sensor for comfortable and unobtrusive monitoring
- Integrated design for seamless use with oxygen therapy
- Continuous, real-time monitoring of exhaled CO2 levels
- Suitable for use in home care, emergency care, and procedural sedation settings